The effect of an SGLT2 inhibitor on sleep apnea in obese patients with sleep apnea syndrome and type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 27 May 2016
At a glance
- Drugs Canagliflozin (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 27 May 2016 New trial record